Companion Diagnostics

Leverage the expertise behind one of the most successful companion diagnostics on the market to advance your companion diagnostic programs

  • Prototype test development (e.g. PD-L1 assay for lung carcinoma clinical study) 
  • Expert consultation for:

- Optimal antibody selection
- Appropriate scoring scheme
- Pivotal cut-off decisions
- Strategy for testing & commercialization

  • Prospective testing of clinical samples (CLIA)
  • Accumulation of pivotal data
  • Validation reports for inclusion in regulatory filings
  • Logical & cost-effective approach

To propel your projects with The Power of Discovery.™

Contact Us Today

Let us know about your project!